Active ingredientDexamfetamineCat. No. P-D069-001CAS 51-64-9Family · Pharmaceutical analytical standards
Dexamfetamine
The dextrorotatory enantiomer of amphetamine, a central nervous system stimulant: introduced as tablets in 1937, it is used for attention deficit hyperactivity disorder (ADHD) and narcolepsy. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Amphetamine was synthesised in 1887 in Berlin by Romanian chemist Lazăr Edeleanu, who called it phenylisopropylamine: its stimulant effects remained unknown until 1927.
Go to the active ingredient →Active ingredientDexamfetamineCat. No. P-D069-001CAS 51-64-9
Pharmacopoeial impurityDexamfetamine Sulfate EP Impurity C (HCl salt)Cat. No. P-D069-002CAS 72739-14-1
Impurity1-Phenyl-2-propanolCat. No. P-D069-003CAS 698-87-3![[(1E)-2-Nitro-1-propen-1-yl]benzene](https://img.vitasanlabs.com/vsl-struct/P-D069-004.svg?v=41e934f030)
Impurity[(1E)-2-Nitro-1-propen-1-yl]benzeneCat. No. P-D069-004CAS 18315-84-9
Active ingredientDexamfetamine HydrochlorideCat. No. P-D069-005CAS 1462-73-3
Active ingredientDexamfetamine SulfateCat. No. P-D069-006CAS 51-63-8No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceDexamfetamine sulfate CRSEDQM code Y0002072Family DexamfetamineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.